BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 32369020)

  • 1. The antibiotic bedaquiline activates host macrophage innate immune resistance to bacterial infection.
    Giraud-Gatineau A; Coya JM; Maure A; Biton A; Thomson M; Bernard EM; Marrec J; Gutierrez MG; Larrouy-Maumus G; Brosch R; Gicquel B; Tailleux L
    Elife; 2020 May; 9():. PubMed ID: 32369020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage defense mechanisms against intracellular bacteria.
    Weiss G; Schaible UE
    Immunol Rev; 2015 Mar; 264(1):182-203. PubMed ID: 25703560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antituberculous drugs modulate bacterial phagolysosome avoidance and autophagy in Mycobacterium tuberculosis-infected macrophages.
    Genestet C; Bernard-Barret F; Hodille E; Ginevra C; Ader F; Goutelle S; Lina G; Dumitrescu O;
    Tuberculosis (Edinb); 2018 Jul; 111():67-70. PubMed ID: 30029917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the Outcomes of New Short-Course Regimens for Multidrug-Resistant Tuberculosis Using Intrahost and Pharmacokinetic-Pharmacodynamic Modeling.
    Doan TN; Cao P; Emeto TI; McCaw JM; McBryde ES
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimycobacterial effect of IFNG (interferon gamma)-induced autophagy depends on HMOX1 (heme oxygenase 1)-mediated increase in intracellular calcium levels and modulation of PPP3/calcineurin-TFEB (transcription factor EB) axis.
    Singh N; Kansal P; Ahmad Z; Baid N; Kushwaha H; Khatri N; Kumar A
    Autophagy; 2018; 14(6):972-991. PubMed ID: 29457983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoevasion and immunosuppression of the macrophage by Mycobacterium tuberculosis.
    Hmama Z; Peña-Díaz S; Joseph S; Av-Gay Y
    Immunol Rev; 2015 Mar; 264(1):220-32. PubMed ID: 25703562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis and the art of macrophage manipulation.
    Upadhyay S; Mittal E; Philips JA
    Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29762680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host-Pathogen Interaction as a Novel Target for Host-Directed Therapies in Tuberculosis.
    Abreu R; Giri P; Quinn F
    Front Immunol; 2020; 11():1553. PubMed ID: 32849525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An experimental analysis of the curative action of penicillin in acute bacterial infections. III. The effect of suppuration upon the antibacterial action of the drug.
    SMITH MR; WOOD WB
    J Exp Med; 1956 Apr; 103(4):509-22. PubMed ID: 13306859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired resistance of Mycobacterium tuberculosis to bedaquiline.
    Andries K; Villellas C; Coeck N; Thys K; Gevers T; Vranckx L; Lounis N; de Jong BC; Koul A
    PLoS One; 2014; 9(7):e102135. PubMed ID: 25010492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis.
    Machado D; Pires D; Perdigão J; Couto I; Portugal I; Martins M; Amaral L; Anes E; Viveiros M
    PLoS One; 2016; 11(2):e0149326. PubMed ID: 26919135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bedaquiline Inhibits the ATP Synthase in Mycobacterium abscessus and Is Effective in Infected Zebrafish.
    Dupont C; Viljoen A; Thomas S; Roquet-Banères F; Herrmann JL; Pethe K; Kremer L
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Halting ionic shuttle to disrupt the synthetic machinery-Structural and molecular insights into the inhibitory roles of Bedaquiline towards Mycobacterium tuberculosis ATP synthase in the treatment of tuberculosis.
    Salifu EY; Agoni C; Olotu FA; Dokurugu YM; Soliman MES
    J Cell Biochem; 2019 Sep; 120(9):16108-16119. PubMed ID: 31125144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Perspective of ATP Synthase Inhibitors in the Management of the Tuberculosis.
    Divita KM; Khatik GL
    Curr Top Med Chem; 2021; 21(18):1623-1643. PubMed ID: 34517802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP stimulates human macrophages to kill intracellular virulent Mycobacterium tuberculosis via calcium-dependent phagosome-lysosome fusion.
    Kusner DJ; Barton JA
    J Immunol; 2001 Sep; 167(6):3308-15. PubMed ID: 11544319
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Sharma N; Shariq M; Quadir N; Singh J; Sheikh JA; Hasnain SE; Ehtesham NZ
    Front Immunol; 2021; 12():696491. PubMed ID: 34322125
    [No Abstract]   [Full Text] [Related]  

  • 18. Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism.
    Koul A; Vranckx L; Dhar N; Göhlmann HW; Özdemir E; Neefs JM; Schulz M; Lu P; Mørtz E; McKinney JD; Andries K; Bald D
    Nat Commun; 2014 Feb; 5():3369. PubMed ID: 24569628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empirical ways to identify novel Bedaquiline resistance mutations in AtpE.
    Karmakar M; Rodrigues CHM; Holt KE; Dunstan SJ; Denholm J; Ascher DB
    PLoS One; 2019; 14(5):e0217169. PubMed ID: 31141524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple Mycobacterial ATP-synthase mutations impedes Bedaquiline binding: Atomistic and structural perspectives.
    Salifu EY; Agoni C; Olotu FA; Soliman MES
    Comput Biol Chem; 2020 Apr; 85():107204. PubMed ID: 31981966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.